Mepron (atovaquone) is a prescription medication used primarily for the treatment and prevention of Pneumocystis pneumonia (PCP), a serious lung infection that commonly affects individuals with weakened immune systems, such as those with HIV/AIDS. Mepron works by inhibiting the growth of the Pneumocystis jirovecii fungus, which causes PCP.

Mepron is also used in the treatment of certain types of malaria, particularly in cases where other treatments are not suitable. It is administered orally in the form of a liquid suspension, making it easier to take, especially for those who may have difficulty with tablets.

Key Features:

• Effective Against PCP: Treats and prevents Pneumocystis pneumonia, a common opportunistic infection in immunocompromised patients.
• Anti-Malarial Use: Also effective in treating specific types of malaria.
• Oral Suspension: Comes in a liquid form for ease of administration.
• Targeted Action: Works by inhibiting the growth of the fungus causing PCP and parasites causing malaria.
• Convenient Dosing: Suitable for use in patients who have difficulty taking oral tablets.